Cargando…

A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study

BACKGROUND: The concordance rate of human epidermal growth factor receptor 2 (HER2) status between core needle biopsy (CNB) and subsequent excisional biopsies of the same tumor varies from 81 to 96%, which may cause inappropriate neoadjuvant therapy that impair the potential benefit from HER2 target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huimin, Xie, Peiling, Li, Zhuoying, Huang, Rong, Feng, Weiliang, Kong, Yanan, Xu, Feng, Zhao, Lin, Song, Qingkun, Li, Jing, Zhang, Baoning, Fan, Jinhu, Qiao, Youlin, Xie, Xiaoming, Zheng, Shan, He, Jianjun, Wang, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500005/ https://www.ncbi.nlm.nih.gov/pubmed/31054583 http://dx.doi.org/10.1186/s13000-019-0806-4

Ejemplares similares

The Diverse Distribution of Risk Factors between Breast Cancer Subtypes of ER, PR and HER2: A 10-Year Retrospective Multi-Center Study in China
por: Song, Qingkun, et al.
Publicado: (2013)

A nation-wide multicenter 10-year (1999–2008) retrospective study of chemotherapy in Chinese breast cancer patients
por: Li, Qiao, et al.
Publicado: (2017)

A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape
por: Xie, Peiling, et al.
Publicado: (2021)

A Nation-Wide Multicenter Retrospective Study of the Epidemiological, Pathological and Clinical Characteristics of Breast Cancer In Situ in Chinese Women in 1999 - 2008
por: Kong, Yanan, et al.
Publicado: (2013)

A nomogram to predict the probability of axillary lymph node metastasis in female patients with breast cancer in China: A nationwide, multicenter, 10-year epidemiological study
por: Zhang, Jian, et al.
Publicado: (2016)

Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis
por: Sun, Wanyi, et al.
Publicado: (2023)

Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China
por: Xue, Peng, et al.
Publicado: (2023)

Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer
por: Yang, Anli, et al.
Publicado: (2021)

Clinical-radiomics nomogram for identifying HER2 status in patients with breast cancer: A multicenter study
por: Fang, Caiyun, et al.
Publicado: (2022)

Generation of a Novel SORT1×HER2 Bispecific Antibody–Drug Conjugate Targeting HER2-Low-Expression Tumor
por: Zhuang, Weiliang, et al.
Publicado: (2023)

Evaluation of outcome of chemotherapy for breast cancer patients older than 70 years: A SEER-based study
por: Pu, Shengyu, et al.
Publicado: (2023)

EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer
por: Ye, Peng, et al.
Publicado: (2022)

Development of an Immune-Related Prognostic Signature in Breast Cancer
por: Xie, Peiling, et al.
Publicado: (2020)

Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer
por: Xie, Xinhua, et al.
Publicado: (2019)

Bioinformatics analysis for the role of CALR in human cancers
por: Li, Yijun, et al.
Publicado: (2021)

A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cm
por: Li, Yijun, et al.
Publicado: (2022)

Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
por: Chen, Heyan, et al.
Publicado: (2023)

Nomogram for Predicting the Postoperative Venous Thromboembolism in Spinal Metastasis Tumor: A Multicenter Retrospective Study
por: Zhang, Hao-ran, et al.
Publicado: (2021)

A nomogram for predicting the HER2 status of circulating tumor cells and survival analysis in HER2-negative breast cancer
por: Yang, Yuqin, et al.
Publicado: (2022)

Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
por: Xu, Aqiao, et al.
Publicado: (2022)

RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients
por: Wang, Haibo, et al.
Publicado: (2022)

Nomograms Involving HER2 for Predicting Lymph Node Metastasis in Early Gastric Cancer
por: Mei, Yu, et al.
Publicado: (2021)

A multicenter, hospital-based and non-inferiority study for diagnostic efficacy of automated whole breast ultrasound for breast cancer in China
por: Xin, Yujing, et al.
Publicado: (2021)

The nodal positivity rate in breast pCR patients with initially, clinically node-negative breast cancer after neoadjuvant systemic therapy: A systematic review and meta-analysis
por: Ma, Le, et al.
Publicado: (2023)

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
por: Liu, Peng, et al.
Publicado: (2019)

Application of intraoperative frozen section examination in the management of female breast cancer in China: a nationwide, multicenter 10-year epidemiological study
por: Wang, Ke, et al.
Publicado: (2014)

Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study
por: Liu, Yang, et al.
Publicado: (2017)

Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: A nationwide multicenter retrospective study
por: Du, Zhuoying, et al.
Publicado: (2020)

Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
por: Yang, Huan, et al.
Publicado: (2020)

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China
por: Song, Ziqian, et al.
Publicado: (2023)

Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study
por: Wu, Jiangwen, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer
por: Wen, Jiahuai, et al.
Publicado: (2016)

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
por: Zou, Yutian, et al.
Publicado: (2022)

Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study
por: Zhang, Lili, et al.
Publicado: (2021)

A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer
por: Li, Yijun, et al.
Publicado: (2021)

Nomogram for predicting disease-free survival among a multicenter cohort of Chinese patients with locally advanced rectal cancer
por: Li, Zhen-Hui, et al.
Publicado: (2019)

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China
por: Han, Yi-Qun, et al.
Publicado: (2021)

Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China
por: Xue, Peng, et al.
Publicado: (2022)

A novel nutrition-related nomogram for the survival prediction of colorectal cancer-results from a multicenter study
por: Ruan, Guo-Tian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kndom0mmf0h8bdmslevaqivib2